Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00266916 · ClinicalTrials.gov registry record

Percutaneous Interventions in Adults With CHD

A clinical trial, sponsored by Children's Healthcare of Atlanta.

Terminated
Registry status
9
Enrollment target

NCT00266916: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.

NCT00266916 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00266916 was terminated before completion, sponsored by Children's Healthcare of Atlanta.

TERMINATED
Registry status
9 participants
Enrollment target

Study Summary

The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocrit in patients with complex cyanotic congenital heart disease who are not candidates for surgical repair.

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 1996-01
Est. Completion 2006-08
Children's Healthcare of Atlanta

80 total trials

Why NCT00266916 stopped before completion

NCT00266916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00266916 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00266916 about?

NCT00266916 is a clinical study titled "Percutaneous Interventions in Adults With CHD". The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocrit in patients with complex cyanotic congenital heart disease who are not candidates for surgical rep...

What is the current status of trial NCT00266916?

This trial is currently terminated. The enrollment target is 9 participants. The study started on 1996-01. Estimated completion is 2006-08.

Who is sponsoring clinical trial NCT00266916?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00266916, the US trial registry maintained by the National Library of Medicine. NCT00266916 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.